Management of immune checkpoint inhibitor‐related dermatologic adverse events

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. The unique spectrum of immune‐related adverse events (IrAEs) may occur during treatment. Dermatologic toxicities appear to be one of the most prevalent immunotherapy‐related adverse events. The most common symptoms are maculop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Autores principales: Si, Xiaoyan, He, Chunxia, Zhang, Li, Liu, Xiaowei, Li, Yue, Wang, Hanping, Guo, Xiaoxiao, Zhou, Jiaxin, Duan, Lian, Wang, Mengzhao
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Clinical Guideline
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6997012/
https://ncbi.nlm.nih.gov/pubmed/31814310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares